The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...

These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...

In vivo studies demonstrate robust and durable gene silencing across rodents and non-human primates Megalin-targeting ligand-siRNA conjugates ...

A defined, xeno-free culture medium from Takara Bio Europe is opening new possibilities for large-scale production of ...